Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001106578-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | F - Tax | $536.12 | -29.2K | 56.1K | -34% | -$15.65M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | — | +69.6K | 69.7K | +53,522% | — |
| DM | 2026-03-17 | 2026-03-15 | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -69.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | F | D | 15,559 | $536.12 | 40,513 | D | — | — | (F2) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-03-15 | F | D | 13,637 | $536.12 | 56,072 | D | — | — | (F2) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 32,499 | — | 32,629 | D | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
| 4 | Common | Common Stock | 2026-03-15 | M | A | 37,080 | — | 69,709 | D | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
| 5 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 37,080 | $0.00 | 0 | D | — · — to — | 37,080 Common Stock | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F7) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2026. |
| 6 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 32,499 | $0.00 | 0 | D | — · — to — | 32,499 Common Stock | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F7) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2026. |